Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

During the Trading Day
0.712 -0.018 / -2.47%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.70 -0.012 / -1.69%
 
Volume: 600.00

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 1.25. The median estimate represents a +321.35% increase from the last price of 0.71.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Rexahn Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.03
Sales
$0.00
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -166.70%
 
 
 
 
 
 
Growthannually -4.55%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account